Tirzepatide Outperforms Dulaglutide for Type 2 Diabetes Control
For patients with type 2 diabetes (T2D) who haven’t adequately controlled their blood glucose, taking the glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide may benefit from switching to GLP-1 tirzepatide rather than upping their dosage.
For patients with type 2 diabetes (T2D) who haven’t adequately controlled their blood glucose, taking the glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide may benefit from switching to GLP-1 tirzepatide rather than upping their dosage.
